Figure 1From: Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening Hepatitis B and hepatitis C prevalence (%) in the general population by country, Europe, 2000–2009. a. Hepatitis B surface antigen (HBsAg) prevalence (%). b. Hepatitis C (anti-HCV-antibody) prevalence (%).Back to article page